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Inpatient Urine Cultures Are Frequently Performed Without
Urinalysis or Microscopy: Findings From a Large Academic
Medical Center
Abigail L. Carlson, MD;1 Satish Munigala, MBBS, MPH;1 Anthony J. Russo, MPH;2 Kathleen M. McMullen, MPH, CIC;2
Helen Wood, RN, MA, CIC;2 Ronald Jackups, MD, PhD;3 David K. Warren, MD, MPH1

objective.
design.
setting.
patients.

To describe the frequency of urine cultures performed in inpatients without additional testing for pyuria.

Retrospective cohort study.
A 1,250-bed academic tertiary referral center.
Hospitalized adults.

methods. This study included urine cultures drawn on 4 medical and 2 surgical wards from 2009 to 2013 and in the medical and surgical
intensive care units (ICUs) from 2012 to 2013. Patient and laboratory data were abstracted from the hospital’s medical informatics database. We
identiﬁed catheter-associated urinary tract infections (CAUTIs) in the ICUs by routine infection prevention surveillance. Cultures without
urinalysis or urine microscopy were deﬁned as “isolated.” The primary outcome was the proportion of isolated urine cultures obtained. We used
multivariable logistic regression to assess predictors of isolated cultures.
results. During the study period, 14,743 urine cultures were obtained (63.5 cultures per 1,000 patient days) during 11,820 patient
admissions. Of these, 2,973 cultures (20.2%) were isolated cultures. Of the 61 CAUTIs identiﬁed, 31 (50.8%) were identiﬁed by an isolated
culture. Predictors for having an isolated culture included male gender (adjusted odds ratio [aOR], 1.22; 95%; conﬁdence interval [CI], 1.11–
1.35], urinary catheterization (aOR, 2.15; 95% CI, 1.89–2.46), ICU admission (medical ICU aOR, 1.72; 95% CI, 1.47–2.00; surgical ICU aOR,
1.82; 95% CI, 1.51–2.19), and obtaining the urine culture ≥1 calendar day after admission (1–7 days aOR, 1.91; 95% CI. 1.71–2.12; >7 days after
admission aOR, 2.81; 95% CI, 2.37–3.34).
conclusions. Isolated urine cultures are common in hospitalized patients, particularly in patients with urinary catheters and those in ICUs.
Interventions targeting inpatient culturing practices may improve the diagnosis of urinary tract infections.
Infect Control Hosp Epidemiol 20 17 ; 38 :4 5 5– 4 60

Differentiating asymptomatic bacteriuria from urinary tract
infection (UTI) is a common diagnostic challenge among
hospitalized patients. Data on the epidemiology of bacteriuria
and pyuria in the inpatient setting are limited. For patients
with urinary catheters, the incidence of bacteriuria is 3%–8%
per day, with nearly all catheterized patients becoming
bacteriuric after 1 month.1–3 In a study of hospitalized
patients, the rate of bacteriuria in catheterized patients was
51% versus 18.6% among noncatheterized patients.4
Because the diagnosis of UTI relies on clinical and laboratory
ﬁndings, a positive urine culture alone is insufﬁcient. Urine
culture interpretation in hospitalized patients is complicated by

concurrent illnesses; thus, ﬁndings from urinalysis and/or
urine microscopy can be a useful diagnostic aid. In a study
of outpatient women with uncomplicated UTI symptoms,
the combination of negative leukocyte esterase and nitrite
on urinalysis had a negative predictive value of 98.3% for
bacteriuria of ≥105 colony-forming units (CFU)/mL.5 In
another study of inpatients and outpatients, the same combination had a 100% negative predictive value for bacteriuria of
≥105 CFU/mL.6
Guidelines support the use of urinalysis and/or urine
microscopy to help differentiate UTI from asymptomatic
bacteriuria.1,7 However, data on the use of these tests in
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inpatients are limited. Most studies have been performed
either among outpatients or catheterized inpatients, populations that differ signiﬁcantly from the general inpatient
population.8–14 Here, we describe the frequency of urine
cultures performed in inpatients without additional testing
for pyuria by urinalysis or urine microscopy.

“subsequent” cultures. A positive culture was deﬁned as any
bacterial or fungal growth according to routine hospital
laboratory protocols. The primary analysis included both
initial and subsequent cultures.
CAUTI surveillance was conducted by the hospital’s
infection prevention department and was initiated in BJH
ICUs in January 2012. CAUTI was deﬁned according to
National Healthcare Safety Network deﬁnitions.15,16

m e th o d s
Study Design and Participants

Statistical analysis

We conducted a retrospective, cohort study at Barnes-Jewish
Hospital (BJH), a 1,250-bed academic hospital in St Louis,
Missouri. The study cohort comprised patients who had at
least 1 urine culture performed during admission. Patients
were selected from 4 general medical wards, 2 surgical wards,
the medical intensive care unit (MICU), and the surgical
intensive care unit (SICU). We included patients admitted to
the medical or surgical wards between January 2008 and
December 2013, or to the MICU or SICU between January
2012 and December 2013.

Data were analyzed using SAS version 9.3 software
(SAS Institute, Cary, NC). Descriptive statistics described the
proportion of isolated urine cultures in patient subgroups. For
categorical variables, between-group differences were analyzed
using χ2 or univariable logistic regression where appropriate.
For continuous variables, differences were assessed using the
Student t test and the Wilcoxon signed-rank test.
To determine independent risk factors associated with
performance of isolated urine cultures, we conducted a
per-patient analysis. We categorized patients based on their
initial culture of the admission to limit bias from
overrepresentation of patients with multiple urine cultures.
Forward, stepwise, multivariable logistic regression analysis
was used to identify risk factors for isolated culture. A P value
≤.15 was used to allow variable entrance into the model, and a
P value ≤ .05 was required to remain in the ﬁnal model.
We determined the proportion of CAUTIs identiﬁed by an
isolated urine culture within the MICU and SICU. For the
CAUTI assessment, we again only used the initial culture of the
admission to avoid bias from overrepresentation.
P values < .05 were considered statistically signiﬁcant for all
tests. The Washington University Human Research Protection
Ofﬁce approved this study.

Data Collection
We abstracted urine diagnostic data from the BJH electronic
medical informatics database, including culture collection
date, location (the unit on which the culture was obtained),
culture result, and specimen type (clean catch versus
catheterized), as well as any urinalysis and urine microscopy
with test date, location, and results. For cultures with
accompanying urinalysis or microscopy, the difference in
calendar days between the culture and urinalysis and/or
microscopy was calculated. The presence of a urinary catheter
at the time of culture was identiﬁed based on specimen
type per the hospital’s computerized provider order entry
(CPOE) system.
Patient data abstracted from the medical informatics database included demographic data and length of stay.
Admission-associated comorbidities and genito-urologic
procedures were identiﬁed by abstracted International
Classiﬁcation of Diseases 9th Revision Clinical Modiﬁcation
(ICD-9-CM) codes (Supplementary Table).
Outcomes and Deﬁnitions
The primary study outcome was the proportion of urine
cultures obtained as isolated cultures. We deﬁned an isolated
urine culture as a one without an associated urinalysis and/or
urine microscopy performed within 1 calendar day before or
after the culture. The secondary outcome was the proportion
of catheter-associated urinary tract infections (CAUTIs)
identiﬁed among ICU patients with isolated urine cultures.
The ﬁrst urine culture obtained from the patient during the
hospital admission was termed the “initial” culture. Urine
cultures performed after the ﬁrst culture of an admission were

resul ts
During the study period, 11,826 admissions met the inclusion
criteria. We excluded 6 admissions due to incomplete data. In
total, 14,743 cultures (11,820 initial and 2,923 subsequent
cultures) performed during 11,820 admissions were analyzed
(range, 1–12 cultures per admission) (Figure 1).
Subsequent cultures were more likely to be ordered for
patients with urinary catheters than were initial cultures
(27.1% vs 12.2%; P < .001). Of the 14,743 urine cultures
obtained, 6,452 (43.8%) were positive for microbial growth.
Initial cultures were more likely to be positive than subsequent
cultures (44.4% vs 41.2%; P = .002).
The overall urine culture rate was 63.5 cultures per 1,000
patient days. The MICU had the greatest frequency of urine
cultures (133.5 per 1,000 patient days), followed by the
medical wards (63.5 per 1,000 patient days), the SICU (53.8
per 1,000 patient days), and the surgical wards (53.6 per 1,000
patient days). ICUs had a higher incidence of urine cultures
than non-ICU units (85.7 vs 58.8 per 1,000 patient days;
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Summary of urine cultures performed in the study units.

P < .001), as did medical versus surgical units (63.5 vs 53.6 per
1,000 patient days; P < .001).
In total, 2,973 urine cultures (20.2%) were isolated
cultures, (ie, sent without urinalysis and/or urine microscopy),
for a rate of 12.8 isolated cultures per 1,000 patient
days (Table 1). Isolated cultures were most common in the
SICU (37.9% of urine cultures obtained), followed by the
MICU (32.9%), surgical wards (18.9%), and medical wards
(15.9%). Subsequent cultures were more likely to be isolated
cultures than initial cultures (28.2% vs 18.2%; P < .001). In
catheterized patients, 878 cultures (39.3%) were isolated,
and 30 cultures (25.6%) in patients with genitourologic
procedures were isolated. Of the 2,973 isolated cultures,
1,050 (35.3%) were positive for microbial growth.
We identiﬁed 2,150 (18.2%) initial urine cultures of each
admission as isolated cultures (Table 2). Several factors were
independently associated with isolated initial urine culture: male
sex, white race, ICU admission, urinary catheterization, and
culture sent ≥1 calendar day after admission. Older age
and diabetes mellitus conferred a lower risk of isolated urine
cultures being obtained. We performed a sensitivity analysis
comparing isolated urine cultures redeﬁned as those without a
urinalysis and/or microscopy sent within 2 calendar days to the
original deﬁnition of 1 calendar day. This resulted in a slight
decline in the proportion of isolated cultures (1,984 [16.8%] vs
2,150 [18.2%]). We also compared patients who had only
isolated cultures obtained during their admission to those
having at least 1 culture sent with accompanying urinalysis
or microscopy, with no signiﬁcant change in our ﬁndings
(data not shown).
Infection prevention surveillance identiﬁed 61 CAUTIs in
the ICUs during the study period, representing 2.2% of all ICU
cultures performed. The SICU had signiﬁcantly more CAUTIs
identiﬁed per culture than the MICU (37 of 1,031 vs 24 of
1,710, P = .002). Of the 61 CAUTIs identiﬁed, 31 (50.8%)
were based on an isolated culture. There was no signiﬁcant
difference between the MICU and SICU in the proportion of
isolated urine cultures identiﬁed as CAUTIs (14 of 562 [2.5%]
vs 17 of 391 [4.3%]; P = .112).

d is c u s s i o n
Urine culturing was a frequent practice in our study units.
Although the majority of urine cultures were accompanied by
orders for urinalysis and/or urine microscopy, 1 in 5 cultures
was sent without additional workup. Among catheterized
patients, more than one-third of cultures were sent without an
associated urinalysis or microscopy. Approximately 50% of
CAUTIs identiﬁed in the ICUs during the 2-year study period
were identiﬁed on the basis of an isolated culture.
Urine culture rates varied by unit type, with higher rates
noted on medical versus surgical units. The MICU had a urine
culture rate more than double the composite rate. A recently
published study from 2 Veterans Affairs hospitals reported
baseline urine culture rates of 41.2 and 43.9 per 1,000 patient
days, respectively, while a study of adult ICUs at an academic
medical center in Maryland found a baseline rate of 139 cultures per 1,000 patient days.17,18 These reports demonstrate
the high variability in culture rates among and within
institutions.
In our study, male sex, white race, ICU admission, catheterization, and culture performed ≥1 calendar day after
admission were all independent risk factors for an isolated
urine culture, with the largest differences seen in the latter 3
categories. Interventions targeted to ICUs, catheterized
patients, and postadmission cultures may therefore have the
greatest effect in decreasing isolated culture rates. Positive
urine cultures were more common among initial cultures
versus subsequent cultures, and in cultures sent with urinalysis
and/or microscopy. Our analysis of this ﬁnding was limited by
the inability to assess the clinical indications for culture.
However, these data suggest a potential positive relationship
between the clinical assessment of UTI and the ordering of an
appropriate workup.
The odds of a culture being performed without urinalysis or
microscopy may also be affected by the structure of the
hospital’s CPOE system. The presentation of testing options to
the provider by the CPOE system may alter ordering practices.
For example, at the time of the study, the medicine service’s
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table 1.

Characteristics of 14,743 Urine Cultures Obtained From Patients on Study Units

Variable

Total Cultures,
No. (%)
(n = 14,743)

Urine Cultures With Urinalysis
and/or Microscopy, No. (%)
(n = 11,770)

Isolated Urine Cultures,
No. (%)
(n = 2,973)a

P Value

6,829 (46.3)
60 ± 18.4

5,300 (45.0)
60 ± 18.3

1,529 (51.4)
57 ± 18.3

<.001
<.001

8,812 (59.8)
5,931 (40.2)
1,098 (7.4)
1,641 (11.1)
1,174 (8.0)
165 (1.1)
2,991 (20.3)
581 (3.9)
678 (4.6)
2,234 (15.2)
117 (0.8)
6,450 (43.7)

6,876 (58.4)
4,894 (41.6)
892 (7.6)
1,342 (11.4)
898 (7.6)
129 (1.1)
2,483 (21.1)
417 (3.5)
571 (4.9)
1,356 (11.5)
87 (0.7)
5,400 (45.9)

1,936 (65.1)
1,037 (34.9)
206 (6.9)
299 (10.1)
276 (9.3)
36 (1.2)
508 (17.1)
164 (5.5)
107 (3.6)
878 (29.5)
30 (1.0)
1,050 (35.3)

<.001
<.001
.23
.04
.003
.60
<.001
<.001
.004
<.001
.14
<.001

8,220 (55.8)
3,782 (25.7)
1,710 (11.6)
1,031 (7.0)

6,914 (58.7)
3,068 (26.1)
1,148 (9.8)
640 (5.4)

1,306 (43.9)
714 (24.0)
562 (18.9)
391 (13.2)

Reference
<.001
<.001
<.001

5,798 (39.3)
7,022 (47.6)
1,923 (13.0)

5,136 (43.6)
5,394 (45.8)
1,240 (10.5)

662 (22.3)
1,628 (54.8)
683 (23.0)

Reference
<.001
<.001

Male
Age, y, mean ± SD
Race
White
Other
Congestive heart failure
Chronic obstructive pulmonary disease
Malignancy
HIV infection
Diabetes mellitus
Cirrhosis
End-stage renal disease
Urinary catheterization
Genito-urologic procedureb
Positive urine culturec
Service
Medical
Surgical
Medical ICU
Surgical ICU
Days from admission to culture
Same day
Within 1–7 d
>7 d
NOTE.
a

SD, standard deviation; HIV, human immunodeﬁciency virus; ICU, intensive care unit.
Cultures without associated urinalysis or urine microscopy performed within 1 calendar day of the culture.
b
As deﬁned by the National Healthcare Safety Network15,16 based on ICD-9-CM procedure codes; includes kidney and prostate procedures, and
vaginal hysterectomy.
c
Culture positive for bacterial or fungal growth.

admission order set for non-ICU patients contained check
boxes for urine microscopy and urine culture, potentially
prompting providers to order both tests simultaneously. We
were unable to assess speciﬁc methods of order entry in our
study, such as the use of order sets or provider responses to
presented order options. However, further research on
provider behaviors within CPOE systems could improve the
design of such interventions.
With the increasing focus on reimbursement of healthcareacquired infections, it is concerning that half of the CAUTIs
identiﬁed in study ICUs were based on an isolated urine
culture. Even adjusting for catheterization status, ICU patients
were at greater risk of having isolated cultures. Without chart
review, we cannot comment on the concordance between
CAUTI surveillance deﬁnitions and clinical illness, nor can we
infer how performing urinalysis or microscopy may impact
CAUTI rates. Also, we could not directly assess a provider’s
rationale for ordering an isolated culture in the ICU. Given the
higher proportion of ICU patients with urinary catheters and
the surveillance focus on ICU CAUTIs, a better understanding
of provider practices in this context is needed.

Our study was limited by the absence of chart review, which
prevented us from evaluating testing indications, treatment,
provider characteristics (eg, level of training), and other
aspects of provider behavior. Certain cultures may have been
performed for reasons other than UTI diagnosis, as in
pregnant women and in certain preprocedure protocols.
Although we attempted to limit such cultures by excluding
gynecologic, obstetric, and urology wards, we were unable to
assess all cultures for these indications. Additionally, comorbidities and genito-urologic procedures were identiﬁed based
only on ICD-9-CM codes. CAUTI surveillance was not routine
on medical and surgical ﬂoors during the study period, so
CAUTI rates for these units were unavailable. We did not
include data on antibiotic use; thus, we were unable to assess
the impact of a positive culture with or without urinalysis on
treatment. The setting of a single academic hospital also limits
the generalizability of results. Strengths of our study include
a large sample size and the inclusion of key clinical data,
such as catheterization status and recent genito-urologic
procedures. Using electronically available data, automated
tracking of future interventions is feasible.
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Comparison of Patient Risk Factors for Isolated Initial Urine Cultures

Variable
Male sex
White racec
Age, y, mean ± SD
CHF
COPD
Malignancy
HIV
Diabetes mellitus
Cirrhosis
ESRD
Urinary catheterization
Genito-urologic procedured
Positive urine culturee
Service
Medical
Surgical
MICU
SICU
ICU admission
Days from admission to culture
Same day
1–7 d
>7 d

Multivariable Analysisb

Initial Urine Culture With Urinalysis
and/or Microscopy, No. (%)
(n = 9,670)

Isolated Initial Urine
Cultures, No. (%)
(n = 2,150)a

P Value

4,338 (44.9)
5,606 (58.0)
60 ± 18.5
746 (7.7)
1,133 (11.7)
764 (7.9)
111 (1.1)
2,057 (21.3)
328 (3.4)
476 (4.9)
921 (9.5)
62 (0.6)
4,512 (46.7)

1,113 (51.8)
1,410 (65.6)
57 ± 18.4
139 (6.5)
220 (10.2)
199 (9.3)
28 (1.3)
374 (17.4)
102 (4.7)
94 (4.4)
520 (24.2)
24 (1.1)
735 (34.2)

5,845 (60.4)
2,576 (26.6)
787 (8.2)
462 (4.8)
1,249 (12.9)
4,850 (50.1)
4,247 (43.9)
573 (5.9)

aOR
(95% CI)

P Value

<.001
<.001
<.001
.05
.05
.04
.55
<.001
.003
.28
<.001
.02
<.001

1.22 (1.11–1.35)
1.22 (1.10, 1.35)
0.990 (0.987–0.992)

<.001
<.001
<.001

0.87 (0.77–0.99)

.03

2.15 (1.89–2.46)

<.001

NA

NA

984 (45.8)
585 (27.2)
327 (15.2)
254 (11.8)
581 (27.0)

Reference
<.001
<.001
<.001
<.001

Reference
1.10 (0.98–1.24)
1.72 (1.47–2.00)
1.82 (1.51–2.19)
NA

NA
.15
<.001
<.001
NA

636 (29.6)
1,210 (56.3)
304 (14.1)

Reference
<.001
<.001

Reference
1.91 (1.71–2.12)
2.81 (2.37–3.34)

NA
.02
<.001

NOTE. aOR, adjusted odds ratio; SD, standard deviation; CHF, congestive heart failure; CI, conﬁdence interval; COPD, chronic obstructive
pulmonary disease; ESRD, end-stage renal disease; HIV, human immunodeﬁciency virus; ICU, intensive care unit; MICU, medical intensive
care unit; NA, not applicable; SICU, surgical intensive care unit.
a
Isolated cultures were deﬁned as cultures without associated urinalysis or urine microscopy performed within 1 calendar day of the culture.
Initial cultures were deﬁned as the ﬁrst culture drawn in a given admission.
b
Variables with a signiﬁcance of ≤0.15 were considered for entry into the model, with a signiﬁcance level of ≤0.05 required to stay in the model.
The variables “positive urine culture” and “ICU admission” were not used in constructing the model. All other variables without adjusted odds
ratios reported were not included in the ﬁnal model. See the Methods section for a full description.
c
Other races, as number (%) of total initial urine cultures: 3,982 (33.7%) black, 695 (5.9%) other unspeciﬁed, 104 (0.9%) Asian, 17 (0.1%)
Native American, 4 Hispanic, 1 Paciﬁc Islander, 1 Alaskan Native.
d
As deﬁned by the National Healthcare Safety Network,15,16 based on ICD-9-CM procedure codes. Includes kidney and prostate procedures, and
vaginal hysterectomy.
e
Culture positive for bacterial or fungal growth.

Our data suggest that interventions aimed at improving culturing practices may result in better diagnosis of inpatient UTIs.
Knowledge of the variability of culturing practices across wards
and patients assists in identifying those groups where interventions may be most beneﬁcial. Further research is needed on
testing practices across institutions, provider-related variables
impacting urine culturing practices, and the effects of testing
variability on antibiotic usage and clinical outcomes.
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